Zheng Q - Search Results

1

[Prolonged duration of the routine pegylated-interferon alfa-2a therapy produces superior virological response in HBeAg-positive chronic hepatitis B patients: a single-center cohort study].

Zhu YY, Wu YL, Chen J, Zheng Q, Dong J, Jiang JJ. Zhu YY, et al. Among authors: zheng q. Zhonghua Gan Zang Bing Za Zhi. 2012 Oct;20(10):737-41. doi: 10.3760/cma.j.issn.1007-3418.2012.10.006. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 23207332 Clinical Trial. Chinese.

2

[Mathematical models using conventional laboratory indicators to predict hepatic fibrosis progressing in chronic hepatitis B].

Chen J, Jiang JJ, Zheng Q, Zhu YY. Chen J, et al. Among authors: zheng q. Zhonghua Yi Xue Za Zhi. 2009 Sep 8;89(33):2349-52. Zhonghua Yi Xue Za Zhi. 2009. PMID: 20095359 Chinese.

3

Serum HBV DNA level at week 24 as a proper predictor for the effect of 2-year lamivudine treatment.

Zheng Q, Jiang JJ, Chen J, Zhu YY, Liu YR, Chen YT. Zheng Q, et al. Chin Med J (Engl). 2011 Apr;124(8):1257-60. Chin Med J (Engl). 2011. PMID: 21543007

4

[Factors influencing the curative effect in patients with HBeAgpositive chronic hepatitis B treated with peg-interferon α-2a].

Chen J, Zheng Q, Jiang J, Zheng J. Chen J, et al. Among authors: zheng q, zheng j. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Jul;37(7):714-9. doi: 10.3969/j.issn.1672-7347.2012.07.012. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22886227 Chinese.

5

[Relationship between the changes in immune cells and HBeAg loss following antiviral treatment in chronic hepatitis B patients].

Zheng Q, Zhu YY, Chen J, Liu YR, You J, Zeng DW, Lin S, Jiang JJ. Zheng Q, et al. Zhonghua Gan Zang Bing Za Zhi. 2012 Nov;20(11):801-6. doi: 10.3760/cma.j.issn.1007-3418.2012.11.001. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 23206296 Chinese.

6

[Relation between HBsAg levels during the immune clearance phase of hepatitis B virus infection and liver pathological stages of chronic hepatitis B].

Zeng DW, Dong J, Chen LH, Zhu YY, Chen J, Zheng Q, Liu YR, Jiang JJ. Zeng DW, et al. Among authors: zheng q. Zhonghua Gan Zang Bing Za Zhi. 2012 Oct;20(10):746-50. doi: 10.3760/cma.j.issn.1007-3418.2012.10.008. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 23207334 Chinese.

7

Small hepatitis B surface antigen interacts with and modulates enoyl-coenzyme A hydratase expression in hepatoma cells.

Gong X, Zhu Y, Dong J, Chen J, You J, Zheng Q, Rao Z, Mao Q, Jiang J. Gong X, et al. Among authors: zheng q. Arch Virol. 2013 May;158(5):1065-70. doi: 10.1007/s00705-012-1581-7. Epub 2012 Dec 30. Arch Virol. 2013. PMID: 23275097

8

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

Chen J, Zhu Y, Zheng Q, Jiang J. Chen J, et al. Among authors: zheng q. Hepatol Res. 2014 Aug;44(8):854-62. doi: 10.1111/hepr.12197. Epub 2013 Aug 15. Hepatol Res. 2014. PMID: 23834322

9

[Hepatitis B surface antigen affects the expression of lipid metabolism-related genes in HepG2 cells].

Rao ZL, Dong J, Zhu YY, Chen J, You J, Zheng Q, Jiang JJ. Rao ZL, et al. Among authors: zheng q. Zhonghua Gan Zang Bing Za Zhi. 2013 Aug;21(8):624-30. doi: 10.3760/cma.j.issn.1007-3418.2013.08.014. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 24119745 Chinese.

10

Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.

Zeng DW, Liu YR, Zhang JM, Zhu YY, Lin S, You J, Li YB, Chen J, Zheng Q, Jiang JJ, Dong J. Zeng DW, et al. Among authors: zheng q. PLoS One. 2013 Oct 25;8(10):e77942. doi: 10.1371/journal.pone.0077942. eCollection 2013. PLoS One. 2013. PMID: 24282481 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,711 results

Search Page

Filters